Close Menu

NEW YORK (Genomeweb) - Epic Sciences announced today that it has completed a $52 million Series E financing.

The financing round was led by Blue Ox Healthcare Partners, with participation by Deerfield Management and Varian. Existing investors also participated, including Altos Capital Partners, Genomic Health, Domain Associates, VI Ventures, Alexandria Venture Investments, and Sabby Management.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.